UMass Medical School ranked in the top 30 in NIH fundingDate Posted: Wednesday, January 25, 2017
From a letter written to the UMass community by Chancellor Michael Collins, MD and Dean Terence Flotte, MD:
We write today to share the news that for the first time in our history, UMass Medical School has moved into the top 30 of 139 U.S. medical schools receiving NIH funding.
The Blue Ridge Institute for Medical Research, which tracks and publishes NIH funding data, recently released its 2016 list, ranking UMass Medical School 29th nationally for NIH funding.
This milestone—which represents a rise of ten spots over the course of the last decade—is a testament to the exceptional talent, creativity and innovation of our faculty. That our steady climb in the rankings has occurred during a period of constrained federal funding and increased competition only serves to heighten the significance of this accomplishment and underscore the world-class quality of our science, our people and our distinctive collaborative ethos.
Blue Ridge reports that UMass Medical School received more than $143 million in NIH funding between October 1, 2015, and September 30, 2016; of the medical schools in New England, only Yale and Harvard surpass us on this metric.
Further, when all sources of research funding are taken into account, UMass Medical School currently has more than $288 million in active research—an impressive figure, indeed.
We know that biomedical research is the surest path to a healthier future for our community and people around the world. We also recognize and value the tremendous economic impact that our research enterprise generates on behalf of Massachusetts and the region. Both are critical to our mission as the commonwealth’s only public medical school.
Please accept our sincere congratulations on this historic achievement and our gratitude for your contributions and ongoing partnership.